korrents

korrents · piece

A Quantitative Approach to Vaccine Funding

Jacob Trefethen · 29 May 2025

Read the piece on blog.jacobtrefethen.com ↗

2 korrents from this piece ↓

Jacob Trefethen did not write this page.

Every claim below was made in this piece, quoted word for word and numbered in the order the piece makes them, so you can read it there rather than take our word for it. The sentence above each quote is our reading of the claim, not their wording. Each quote was checked against a stored copy of the page at build time; where the two differ, the quote is the fact.

  1. Our punchline is that R&D spending varies by 10X+ across diseases for no good reason. I've been poking at that punchline for the last six or so years, from different directions, and I am confident it's true.
  2. Infectious diseases as a category receive vastly less R&D spending from industry than non-communicable diseases, per death they cause, because they disproportionately kill people in lower- and middle-income countries where the payoff for making a cure is less lucrative.

Keep reading

The other pieces are the ones whose claims are worded most like this one's. That measures language, not agreement: they may argue the opposite.